Historical record - last NADAC effective date: 11/20/2019
Product Information
RAMIPRIL 2.5 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0719 per EA under NDC 00054010725. Its NADAC has been published 314 times since Nov 28, 2013.
FDA first approved this application on Jun 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054010725
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077900FDA Approved
6/18/2008
TE Code
AB
On Market Since
6/18/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 2.5 MG CAPSULE has been published 314 times since Nov 28, 2013, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0719 per EA |
|---|---|
| All-time high | $0.0900 (Apr 15, 2015) |
| All-time low | $0.0603 (Apr 17, 2019) |
| Median price | $0.0766 |
| Average price | $0.0764 |
| Largest weekly change | +29.9% (May 22, 2019) |
| Weeks tracked | 314 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-13.9%
Last surveyed Nov 27, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 2.5 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0719 per EA (NDC 00054010725), effective Nov 27, 2019.
How has the price of RAMIPRIL 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 2.5 MG CAPSULE has declined 13.9%. It has been tracked across 314 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 2.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 2.5 MG CAPSULE has ranged from a low of $0.0603 (Apr 17, 2019) to a high of $0.0900 (Apr 15, 2015), with a median of $0.0766 per EA.
Are there cheaper alternatives to RAMIPRIL 2.5 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 2.5 MG CAPSULE, is $0.0460 per EA — about 36% below RAMIPRIL 2.5 MG CAPSULE.
Who manufactures RAMIPRIL 2.5 MG CAPSULE?
RAMIPRIL 2.5 MG CAPSULE (NDC 00054010725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.